Kaplan B - Search Results

1

Death after graft loss: an important late study endpoint in kidney transplantation.

Kaplan B, Meier-Kriesche HU. Kaplan B, et al. Am J Transplant. 2002 Nov;2(10):970-4. doi: 10.1034/j.1600-6143.2002.21015.x. Am J Transplant. 2002. PMID: 12482151

2

Pharmacokinetics of an everolimus-cyclosporine immunosuppressive regimen over the first 6 months after kidney transplantation.

Kovarik JM, Kaplan B, Silva HT, Kahan BD, Dantal J, McMahon L, Berthier S, Hsu CH, Rordorf C. Kovarik JM, et al. Among authors: kaplan b. Am J Transplant. 2003 May;3(5):606-13. doi: 10.1034/j.1600-6143.2003.00107.x. Am J Transplant. 2003. PMID: 12752317 Clinical Trial.

3

Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range.

Kovarik JM, Kaplan B, Tedesco Silva H, Kahan BD, Dantal J, Vitko S, Boger R, Rordorf C. Kovarik JM, et al. Among authors: kaplan b. Transplantation. 2002 Mar 27;73(6):920-5. doi: 10.1097/00007890-200203270-00016. Transplantation. 2002. PMID: 11923693 Clinical Trial.

4

Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with sandimmune.

Meier-Kriesche HU, Kaplan B. Meier-Kriesche HU, et al. Among authors: kaplan b. Am J Transplant. 2002 Jan;2(1):100-4. doi: 10.1034/j.1600-6143.2002.020116.x. Am J Transplant. 2002. PMID: 12095048

5

Combined liver-kidney transplants: allosensitization and recipient outcomes.

Askar M, Schold JD, Eghtesad B, Flechner SM, Kaplan B, Klingman L, Zein NN, Fung J, Srinivas TR. Askar M, et al. Among authors: kaplan b. Transplantation. 2011 Jun 15;91(11):1286-92. doi: 10.1097/TP.0b013e3182184181. Transplantation. 2011. PMID: 21478816

6

Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.

Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF. Sis B, et al. Among authors: kaplan b. Am J Transplant. 2009 Oct;9(10):2312-23. doi: 10.1111/j.1600-6143.2009.02761.x. Epub 2009 Jul 22. Am J Transplant. 2009. PMID: 19681822

7

The time is now: formation of true transplant centers.

Howard RJ, Kaplan B. Howard RJ, et al. Among authors: kaplan b. Am J Transplant. 2008 Nov;8(11):2225-9. doi: 10.1111/j.1600-6143.2008.02388.x. Epub 2008 Sep 10. Am J Transplant. 2008. PMID: 18785962

8

Assessing long-term nephron loss: is it time to kick the CAN grading system?

Halloran PF, Langone AJ, Helderman JH, Kaplan B. Halloran PF, et al. Among authors: kaplan b. Am J Transplant. 2004 Nov;4(11):1729-30. doi: 10.1111/j.1600-6143.2004.00662.x. Am J Transplant. 2004. PMID: 15476465 No abstract available.

9

Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?

Meier-Kriesche HU, Schold JD, Kaplan B. Meier-Kriesche HU, et al. Among authors: kaplan b. Am J Transplant. 2004 Aug;4(8):1289-95. doi: 10.1111/j.1600-6143.2004.00515.x. Am J Transplant. 2004. PMID: 15268730

10

Access to quality: evaluation of the allocation of deceased donor kidneys for transplantation.

Schold JD, Kaplan B, Chumbler NR, Howard RJ, Srinivas TR, Ma L, Meier-Kriesche HU. Schold JD, et al. Among authors: kaplan b. J Am Soc Nephrol. 2005 Oct;16(10):3121-7. doi: 10.1681/ASN.2005050517. Epub 2005 Aug 31. J Am Soc Nephrol. 2005. PMID: 16135772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results